JPWO2023026791A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023026791A5 JPWO2023026791A5 JP2023543774A JP2023543774A JPWO2023026791A5 JP WO2023026791 A5 JPWO2023026791 A5 JP WO2023026791A5 JP 2023543774 A JP2023543774 A JP 2023543774A JP 2023543774 A JP2023543774 A JP 2023543774A JP WO2023026791 A5 JPWO2023026791 A5 JP WO2023026791A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- set forth
- sequence set
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 16
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- 239000012634 fragment Substances 0.000 claims 6
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 4
- 230000001225 therapeutic effect Effects 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021139380 | 2021-08-27 | ||
| JP2021139380 | 2021-08-27 | ||
| PCT/JP2022/029636 WO2023026791A1 (ja) | 2021-08-27 | 2022-08-02 | ｃ－ＫＩＴ陽性腫瘍特異的抗体断片 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023026791A1 JPWO2023026791A1 (https=) | 2023-03-02 |
| JPWO2023026791A5 true JPWO2023026791A5 (https=) | 2024-01-11 |
| JP7460063B2 JP7460063B2 (ja) | 2024-04-02 |
Family
ID=85323099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543774A Active JP7460063B2 (ja) | 2021-08-27 | 2022-08-02 | ｃ－ＫＩＴ陽性腫瘍特異的抗体断片 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250215073A1 (https=) |
| EP (1) | EP4393516A1 (https=) |
| JP (1) | JP7460063B2 (https=) |
| CN (1) | CN117980007A (https=) |
| WO (1) | WO2023026791A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
| CN120289629B (zh) * | 2025-04-14 | 2025-09-30 | 军事科学院军事医学研究院军事兽医研究所 | 一种犬瘟热病毒h蛋白单克隆抗体2d1b1及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020179749A1 (ja) | 2019-03-05 | 2020-09-10 | 国立大学法人東海国立大学機構 | 標的特異的複合体及びその用途 |
-
2022
- 2022-08-02 WO PCT/JP2022/029636 patent/WO2023026791A1/ja not_active Ceased
- 2022-08-02 JP JP2023543774A patent/JP7460063B2/ja active Active
- 2022-08-02 US US18/686,639 patent/US20250215073A1/en active Pending
- 2022-08-02 EP EP22861082.0A patent/EP4393516A1/en active Pending
- 2022-08-02 CN CN202280062211.0A patent/CN117980007A/zh active Pending